A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new ...

Researchers examined CA-125 levels at diagnosis, defining them as elevated/borderline or negative/normal in 250,749 patients ...

Black and American Indian patients are less likely to have elevated cancer antigen (CA)-125 levels at ovarian cancer ...

Ovarian cancer is the fifth leading cause of cancer-related deaths among women in the U.S. However, the racial bias makes it ...

A new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying ...

Mexico's premier center for regenerative medicine, anti-aging therapies, and advanced diagnostics, is proud to announce our collaboration with OncoInv - a global leader in multi-cancer early detection ...

In this cohort study of patients with ovarian cancer, American Indian and Black patients were 23% less likely to have an elevated cancer antigen (CA)-125 level at diagnosis. Current CA-125 thresholds ...

The likelihood of having an elevated CA-125 level at ovarian cancer diagnosis was lower for American Indian, Asian, or Black patients versus White patients. HealthDay News — Black and American ...

The new study, supported by grants from the National Cancer Institute and published Thursday in JAMA Network Open, looked at a test called CA-125. The test measures a tumor marker in the blood ...

The cancer antigen (CA)-125 test may miss ovarian cancer in some Black and Native American patients, delaying their treatment ...

In this cohort study of patients with ovarian cancer, American Indian and Black patients were 23% less likely to have an elevated ...